Covers the decline of cancer death rates, conventional and targeted anticancer drugs, surgical oncology, radiotherapy, chemotherapy, resistance mechanisms, and the history of targeted drugs and EGFR targeting.
Explores precision oncology, focusing on predictive biomarkers, big data analysis, NGS applications, immune response mechanisms, and the personalization of immuno-oncology.
